RARE vs THRM · rev $560.2M vs P/E 49, rev $1.46B
Ultragenyx (RARE) versus Gentherm Inc (THRM) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Gentherm Inc (THRM) is a auto parts company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported THRM revenue for 2024-12-31 was $1.46B. Net income was $64.9M. Revenue was down 0.9% from 2023-12-31 to 2024-12-31. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
RARE currently screens at market cap $2.79B. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
Not investment advice. Open the RARE and THRM stock pages for the full models.
Not investment advice.